Perceptions of genetic discrimination among people at risk for Huntington’s disease: A cross sectional survey

BMJ (Online)

Volumn 338, Issue 7708, 2009, Pages

  Bombard, Yvonne ^a,d   Veenstra, Gerry ^a   Friedman, Jan M ^a   Creighton, Susan ^a   Currie, Lauren ^a   Paulsen, Jane S ^b   Bottorff, Joan L ^c   Hayden, Michael R ^a   Guttman, Mark ^e   Giambattista, Christine ^e   Ludman, Mark ^f   Murphy, Jill ^f   Babineau Sturk, Tina ^f   Macleod, Patrick ^g   Rice, Jennifer ^g   Martin, Wayne ^h   Wieler, Marguerite ^h   Meschino, Wendy ⁱ   Gibbons, Clare ⁱ   Raymond, Lynn ^a   Decolongon, Joji ^a   Suchowersky, Oksana ^j   Klimek, Mary Lou ^j   more..

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e Centre for Movement Disorders   (Canada)

^f IWK HEALTH CENTRE   (Canada)

^g VICTORIA GENERAL HOSPITAL   (Canada)

^h UNIVERSITY OF ALBERTA   (Canada)

ⁱ NORTH YORK GENERAL HOSPITAL   (Canada)

^j UNIVERSITY OF CALGARY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CANADA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EMPLOYMENT DISCRIMINATION; FEMALE; GENE MUTATION; HEALTH CARE DISPARITY; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; HUNTINGTON CHOREA; INSURANCE; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; MOTOR DYSFUNCTION; ORGANIZATION AND MANAGEMENT; PERCEPTION; PRIORITY JOURNAL; RACISM; REVIEW; RURAL POPULATION; SELF REPORT; SOCIAL ASPECT; URBAN POPULATION;

ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDIES; EMPLOYMENT; FEMALE; GENETIC COUNSELING; GENETIC TESTING; HUMANS; HUNTINGTON DISEASE; INSURANCE, HEALTH; MALE; MIDDLE AGED; PEDIGREE; PERCEPTION; PREJUDICE; RISK FACTORS; RURAL HEALTH; STRESS, PSYCHOLOGICAL; URBAN HEALTH;

EID: 85010612299     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b2175     Document Type: Article

References (39)

1. Hall MA, McEwen JE, Barton JC, Walker AP, Howe EG, Reiss JA, et al. Concerns in a primary care population about genetic discrimination by insurers. Genet Med 2005;7:311-6.
2. Apse KA, Biesecker BB, Giardiello FM, Fuller BP, Bernhardt BA. Perceptions of genetic discrimination among at-risk relatives of colorectal cancer patients. Genet Med 2004;6:510-6.
3. Peterson EA, Milliron KJ, Lewis KE, Goold SD, Merajver SD. Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population. Cancer Epidemiol Biomarkers Prev 2002;11:79-87.
4. Mayor S. Report warns of danger of genetic discrimination in the workplace. BMJ 2003;327:702.
5. Billings PR, Kohn MA, de Cuevas M, Beckwith J, Alper JS, Natowicz MR. Discrimination as a consequence of genetic testing. Am J Hum Genet 1992;50:476-82.
6. Friedrich MJ. Preserving privacy, preventing discrimination becomes the province of genetics experts. JAMA 2002;288:815-6, 819.
7. Hadley DW, Jenkins J, Dimond E, Nakahara K, Grogan L, Liewehr DJ, et al. Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer. Arch Intern Med 2003;163:573-82.
8. Tanne JH. US Senate outlaws genetic discrimination. BMJ 2008;336:1038.
9. Low L, King S, Wilkie T. Genetic discrimination in life insurance: empirical evidence from a cross sectional survey of genetic support groups in the United Kingdom. BMJ 1998;317:1632-5.
10. Lapham EV, Kozma C, Weiss JO. Genetic discrimination: perspectives of consumers. Science 1996;274:621-4.
11. Morrison PJ. Insurance, unfair discrimination, and genetic testing. Lancet 2005;366:877-80.
12. Quarrell OW, Meredith AL, Tyler A, Youngman S, Upadhyaya M, Harper PS. Exclusion testing for Huntington’s disease in pregnancy with a closely linked DNA marker. Lancet 1987;1:1281-3.
13. Hayden MR, Hewitt J, Kastelein JJ, Langlois S, Wilson RD, Fox S, et al. First-trimester prenatal diagnosis for Huntington’s diseasewithDNA probes. Lancet 1987;1:1284-5.
14. Hayden MR. Huntington’s chorea. New York: Springer-Verlag, 1981.
15. Craufurd DI, Harris R. Ethics of predictive testing for Huntington’s chorea: the need for more information. BMJ 1986;293:249-51.
16. Perry TL. Some ethical problems in Huntington’s chorea. CMAJ 1981;125:1098-100.
17. Harper PS, Gevers S, deWert G, Creighton S, Bombard Y, Hayden MR. Genetic testing and Huntington’s disease: issues of employment. Lancet Neurol 2004;3:249-52.
18. Siesling S, van Vugt JP, Zwinderman KA, Kieburtz K, Roos RA. Unified Huntington’s disease rating scale: reliability and consistency. Huntington Study Group. Mov Disord 1998;13:915-9.
19. Bombard Y, Penziner E, Decolongon J, Klimek ML, Creighton S, Suchowersky O, et al. Managing genetic discrimination: strategies used by individuals found to have the Huntington disease mutation. Clin Genet 2007;71:220-31.
20. Bombard Y, Penziner E, Suchowersky O, Guttman M, Paulsen JS, Bottorff JL, et al. Engagement with genetic discrimination: concerns and experiences in the context of Huntington disease. Eur J Hum Genet 2008;16:279-89.
21. Krieger N, Smith K, Naishadham D, Hartman C, Barbeau EM. Experiences of discrimination: validity and reliability of a self-report measure for population health research on racism and health. Soc Sci Med 2005;61:1576-96.
22. Taylor S, Treloar S, Barlow-Stewart K, Stranger M, Otlowski M. Investigating genetic discrimination in Australia: a large-scale survey of clinical genetics clients. Clin Genet 2008;74:20-30.
23. Borrell LN, Jacobs DR Jr, Williams DR, Pletcher MJ, Houston TK, Kiefe CI. Self-reported racial discrimination and substance use in the coronary artery risk development in adults study. Am J Epidemiol 2007;166:1068-79.
24. Kessler RC, Mickelson KD, Williams DR. The prevalence, distribution, and mental health correlates of perceived discrimination in the United States. J Health Soc Behav 1999;40:208-30.
25. Krieger N, Sidney S, Coakley E. Racial discrimination and skin color in the CARDIA study: implications for public health research. Coronary artery risk development in young adults. Am J Public Health 1998;88:1308-13.
26. Krieger N. Embodying inequality: a review of concepts, measures, andmethods for studying health consequences of discrimination. Int J Health Serv 1999;29:58.
27. Dillman D. Mail and internet surveys: the tailored design method. Toronto: John Wiley and Sons, 2000.
28. Curran-Everett D. Multiple comparisons: philosophies and illustrations. Am J Physiol Regul Integr Comp Physiol 2000;279:R1-8.
29. Babul R, Adam S, Kremer B, Dufrasne S, Wiggins S, Huggins M, et al. Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington Disease. JAMA 1993;270:2321-5.
30. Codori AM, Brandt J. Psychological costs and benefits of predictive testing for Huntington’s disease. Am J Med Genet 1994;54:174-84.
31. Quaid KA, Morris M. Reluctance to undergo predictive testing: the case of Huntington disease. Am J Med Genet 1993;45:41-5.
32. Wiggins S, Whyte P, Huggins M, Adam S, Theilmann J, Bloch M, et al. The psychological consequences of predictive testing for Huntington’s disease. Canadian collaborative study of predictive testing. N Engl JMed 1992;327:1401-5.
33. Greely HT. Banning genetic discrimination. N Engl J Med 2005;353:865-7.
34. Walker FO. Huntington’s disease. Lancet 2007;369:218-28.
35. Sobel SK, Cowan DB. Impact of genetic testing for Huntington disease on the family system. Am J Med Genet 2000;90:49-59.
36. Kessler S. Predictive testing for Huntington disease: a psychologist’s view. Am J Med Genet 1994;54:161-6.
37. Evers-Kiebooms G, Welkenhuysen M, Claes E, Decruyenaere M, Denayer L. The psychological complexity of predictive testing for late onset neurogenetic diseases and hereditary cancers: implications for multidisciplinary counselling and for genetic education. Soc SciMed 2000;51:831-41.
38. Goizet C, Lesca G, Durr A. Presymptomatic testing in Huntington’s disease and autosomal dominant cerebellar ataxias. Neurology 2002;59:1330-6.
39. Hayden MR. Predictive testing for Huntington’s disease: a universal model? Lancet Neurol 2003;2:141-2.